Covid-19: Variant JN.1, Sign, Symptoms, Diagnosis, and Treatment.

  • Unique Paper ID: 189823
  • Volume: 12
  • Issue: 8
  • PageNo: 360-367
  • Abstract:
  • COVID-19, also known as coronavirus disease, is caused by a virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Started spreading at the end of 2019, which is why it’s called COVID-19, and became a pandemic disease in 2020. The prediction was that SARS-CoV-2 emerged from direct transmission of a bat coronavirus to humans. Since the beginning of the pandemic, we have seen several variants, including Alpha, Beta, Delta, and Omicron. SARS-CoV-2 continues to evolve into many variants and sub-variants. In the year 2025, the cases of COVID-19 started to rise again in parts of India, Thailand, Brazil, the UK, and Greece. According to the WHO report taken on the 18th of May 2025, these countries have more cases in comparison to Denmark, Ukraine, and Italy so far. In a significant development, the WHO has recently found a novel strain, JN-1, designating it as a “variant of interest” underlining its potential significance in the ongoing battle against the virus. The recent increase has been linked to the spread of a new subvariant of Omicron, JN-1. This paper is going to review how different variants behave and what precautions may be necessary. The paper will also reveal the new variant JN-1, including its symptoms, precautions, diagnosis, and treatment.

Copyright & License

Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{189823,
        author = {Bandana Pandey},
        title = {Covid-19: Variant JN.1, Sign, Symptoms, Diagnosis, and Treatment.},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {8},
        pages = {360-367},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=189823},
        abstract = {COVID-19, also known as coronavirus disease, is caused by a virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Started spreading at the end of 2019, which is why it’s called COVID-19, and became a pandemic disease in 2020. The prediction was that SARS-CoV-2 emerged from direct transmission of a bat coronavirus to humans. Since the beginning of the pandemic, we have seen several variants, including Alpha, Beta, Delta, and Omicron. SARS-CoV-2 continues to evolve into many variants and sub-variants. In the year 2025, the cases of COVID-19 started to rise again in parts of India, Thailand, Brazil, the UK, and Greece. According to the WHO report taken on the 18th of May 2025, these countries have more cases in comparison to Denmark, Ukraine, and Italy so far. In a significant development, the WHO has recently found a novel strain, JN-1, designating it as a “variant of interest” underlining its potential significance in the ongoing battle against the virus. The recent increase has been linked to the spread of a new subvariant of Omicron, JN-1. This paper is going to review how different variants behave and what precautions may be necessary. The paper will also reveal the new variant JN-1, including its symptoms, precautions, diagnosis, and treatment.},
        keywords = {SARS-CoV-2, Immune response, JN.1, Variants, Treatment},
        month = {January},
        }

Cite This Article

Pandey, B. (2026). Covid-19: Variant JN.1, Sign, Symptoms, Diagnosis, and Treatment.. International Journal of Innovative Research in Technology (IJIRT), 12(8), 360–367.

Related Articles